That includes partners within and beyond the healthcare industry who can bring unique ideas and perspectives to support the health of the whole person, address the social determinants of health and expand access to world-class care when, where and how people need it
A TSH (thyroid-stimulating hormone) test at baseline screens for both hypothyroidism and hyperthyroidism before attributing any metabolic changes to the medication
Analysis in larger and more racially and ethnically diverse population will be needed to confirm and understand the generalizability of these findings Disclosures: Cristian Sanchez Torres: Nothing to Disclose, Ana Ramirez: Nothing to Disclose, Scott Gillespie: Nothing to Disclose, Helaina Huneault: Nothing to Disclose, Jack Knight-Scott: Nothing to Disclose, Adina Alazraki: Nothing to Disclose, Geetika Khanna: Nothing to Disclose, Claudia Yaranga: Nothing to Disclose, Nicola Santoro: Nothing to Disclose, Liliana Aguayo: Nothing to Disclose, Shasha Bai: Nothing to Disclose, Jean Welsh: Nothing to Disclose, Miriam Vos: Nothing to Disclose 865 EFFICACY OF NON INVASIVE TESTS (NITS) IN DIFFERENTIATING METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE (MAFLD) AND METABOLIC-ALCOHOL ASSOCIATED LIVER DISEASE (METALD)-META-ALD STUDY Harsh Tevethia 1 Guresh Kumar 2 Shiv Kumar Sarin 2 , 1 Institute of liver and biliary sciences,New Delhi India, 2 ILBS Background: MAFLD represents a global pandemic for liver diseases with a prevalence of 22% to 51% worldwide
Which Is Better
